Your eligibility depends on your full medical history, current medications, and health goals
In reproductive tissues, peptides may impact follicle development, ovarian signaling, and local inflammation, all of which are important for fertility
But it comes with important caveats: lack of FDA approval, variability risks, and transitional regulatory changes

Stronger Evidence: GHK-Cu: Clinical studies showing collagen increase, wound healing acceleration Matrixyl: Published studies demonstrating wrinkle reduction Multiple in vitro studies confirming mechanisms Moderate Evidence: Snap-8, Argireline: Manufacturer studies and some independent research Clinical observations support efficacy for expression lines Recent Clinical Data (2024-2025): Bioactive collagen peptides: 19.20% increase in dermal thickness after 12 weeks LMW collagen peptides: 46% wrinkle volume reduction in 6 weeks New peptides showing 73% improvement in sagging, 100% fine-line improvement in trials Limitations: Most peptides lack large-scale, independent clinical trials Effects are modest compared to injectable treatments Consistent, long-term use required Individual responses vary Realistic Expectation: Peptides produce measurable but gradual improvements over timethey don't replace procedures but can complement them